baber/WOPTO huggingface dataset:
Patent NZ-335622-A (NZ)
Title: Personal computer lottery game
Inventor: KAYE PERRY SCOTT
IPC: A63F3/08
Filed: 1997-10-21
Abstract: method and system for playing a lottery type game include a gaming piece (340) which includes a predetermined code (steps 11, 17 - not shown) having data indicating whether a player wins or loses the game (steps 19, 26, 54 - not shown) is claimed.  The data is unrecognizable to the player such that the player does not know the outcome of the game prior to play of the game.  The code is stored on the gaming piece (340) in a memory device (342).  The gaming piece is reusable with different codes.  The code is read by a processor (360 - not shown).  The processor presents an amusement game (366, 368, 370 - not shown) on a display for play by the player, and the player controls game play by inputting game parameters to the processor.  The processor controls the outcome of the amusement game played by the player based upon the code (steps 19, 54, 372 - not shown).  A display provides an indication to the player of a game win or loss based on the code.
Patent NZ-335704-A (NZ)
Title: Nested digital modulators for frequency synthesis
Inventor: MANN STEPHEN IAN
IPC: H03L7/197
Filed: 1999-05-11
Abstract: A nested modulator includes first and second digital modulation stages 502, 501 with respective inputs and outputs.  The outputs of the modulation stages are combined in adder 511 to form a common output producing a resultant modulation signal Y.  An input 520 to the first modulation stage 502 is derived from a combination of an external control signal (feedback coefficients) and a feedback signal derived from the resultant modulation signal Y.  The input e to the second stage receives an internal control signal from the first stage, the error signal on line 509, which is a combination of lsbs from latch 504 and msbs from adder 507.  Cascaded modulators including nested modulators may be constructed.
Patent NZ-336495-A (NZ)
Title: post anchor assembly with post received inside collets attached to anchor, and sleeve type clamp located outside post and forced down to clamp it to anchor
Inventor: STUART IAN MATEAR
IPC: E01F9/685
Filed: 1999-06-28
Abstract: round engaging part 1 is driven into the ground.  An upper post receiving portion 2 of part 1 has collets, typically welded to the body of part 1.  Post 2 seats within collets 9 and clamping member 5 is located over post 2 to urge collets towards post 2.
Patent NZ-503272-A (NZ)
Title: syringe to inject fluid into trees and other plants, having spaced intervals for locking plunger relative to barrel
Inventor: DAWSON ALLAN DONALD
IPC: A61M5/48
Filed: 2000-03-09
Abstract: In order to provide pre-set pressurization for a syringe plunger 3 and barrel 2 are selectively inter-engaged via respective projections. Typically, plunger 3 has sleeve 7 with lugs 8 which engage with rows of ribs 10 on barrel 2.
Patent NZ-508165-A (NZ)
Title: Liquid coffee and food product
Inventor: BORLAND CAROL
IPC: A23F5/26
Filed: 1999-07-15
Abstract: A  ready-to-serve  coffee product,  which  provides  a beverage  or  topping.  The  product  is  a  black,   coffee containing  liquid in an aseptically filled  container.  The may  contain  more  than  2 % by weight  of  soluble  coffee solids.  The liquid is produced by extracting coffee  solids from  roast  and ground coffee at a draw-off ratio  of  less than about 3. The concentration of soluble coffee solids  in the  coffee extract is then adjusted to less than about 5  % by weight under oxygen-reduced conditions.
Patent NZ-511700-A (NZ)
Title: Antimicrobial denture cleansing compositions
Inventor: WATKINS C DOUGLAS
IPC: A61L9/04
Filed: 2000-03-24
Abstract: A denture cleansing composition comprises: a monopersulphate compound; an effective amount of a sequestering agent for calculus removal and to provide a pH of the composition in solution in the range of from 3 to 5 and an effective amount of an antimicrobial agent to provide antimicrobial activity to the composition to effectively kill bacteria and other microorganisms during cleansing of dentures. The denture cleansing composition is devoid of perborate compounds.
Patent NZ-514538-A (NZ)
Title: An improved hinge
Inventor: DICKSON GLENN
IPC: E05D11/02
Filed: 2000-04-20
Abstract: An improved hinge assembly for use with gates, doors and the like, including respective first, second and third members, adapted to be releasably and adjustably mounted to a gate, door or the like and a jamb or the like therefor.  The first member (1) has means (10, 11) associated therewith which allows for pivotal movement thereof relative to said second (2) and third members (3), thereby to allow for selective and controlled opening and/or closing of the gate, door or the like.  The assembly further includes means which allows for the monitoring of the disposition of the gate, door or the like relative to the jamb or the like therefor, thereby to denote whether the gate, door of the like is open or closed.  Means are also provided for selective vertical and/or horizontal adjustment of the hinge assembly.
Patent NZ-516793-A (NZ)
Title: Tricyclic inhibitors of poly (ADP-ribose) polymerases
Inventor: WEBBER STEPHEN EVAN
IPC: C07D487/06
Filed: 2000-08-31
Abstract: A 7H-2,7,9a-triaza-benzo[cd]azulen-6-one or 2H- [1,4]diazepine[6,7,1-hi]indol-1-one derivative or a pharmaceutically acceptable derivative thereof has the formula (I) or (II) wherein: X is O or S; Z is O or S; Y is N or CR3; R3 is H, halogen, cyano, optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl or heteroaryl group or -C(W)-R20 or -CR29=N-R30; R1 is cyano, substituted alkyl, or optionally substituted alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl or heteroaryl group or C(O)R12, OR13, S(O)nR16 or NR17R18; R2 is H or alkyl; R4 is H, halogen, or alkyl; R5, R6, R7, and R8 are independently H, an optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl or heteroaryl group or -C(O)-R50; R9 is H or alkyl and R12, R13, R16 to R18, R50, W, R20, R29 and R30 are as defined in the specification; provided in formula (I) when Y is CR3 then R1 to R8 are not all H and in formula (II) R9 is not H when R5 or R6 is alkyl. The compounds are useful for inhibiting PARP activity of an enzyme such as poly (ADP-ribose) polymerase or tankyrase or for inhibiting PARP enzyme activity.
Patent NZ-518315-A (NZ)
Title: Dual X-ray absorptiometry, method and apparatus for determination of properties of food or feed
Inventor: HANSEN PER WAABEN
IPC: G01N23/06
Filed: 2000-10-20
Abstract: A method and apparatus for determination of properties of a medium of food or feed, such as the fat content of meat, by use of dual X-ray absorptiometry, the medium being a raw material of food or feed, a product or intermediary product of food or feed, or a batch, sample or section of the same, specifically for online use in a slaughter house. The method comprises scanning substantially all of the medium by X-ray beams (16, 18) having at least two energy levels, including a low level and a high level, detecting the X-ray beams having passed through the medium for a plurality of areas (pixels) of the medium, for each area calculating a value, Alow, representing the absorption in the area of the medium at the low energy level, for each area calculating a value, Ahigh representing the absorption in the area of the medium at the high energy level. The accuracy of the determination is improved considerably by generating for each area a plurality of values being products of the type Alown * Ahighm wherein n and m are positive and/or negative integers or zero, and predicting the properties of the medium in this area by applying a calibration model to the plurality of values, wherein the calibration model defines relations between the plurality of values and properties of the medium.
Patent NZ-523135-A (NZ)
Title: New phenylpiperazines useful fro treating central nervous system disorders caused by dopaminergic or serotonergic systems
Inventor: FEENSTRA ROELOF W
IPC: A61P25/16
Filed: 2002-02-19
Abstract: Phenylpiperazine derivatives of the formula (I) and their salts that show high affinity for both the dopamine D2 receptor and the serotonin reuptake site, that are active in therapeutic models sensitive to clinically relevant antipsychotics and that can be used for the treatment of affections or diseases of the central nervous system caused by disturbances in either the dopaminergic or serotonergic systems, for example: aggression, anxiety disorders, autism, vertigo, depression, disturbances of cognition or memory, Parkinson's disease and in schizophrenia and other psychotic disorders are disclosed, wherein: R is a group of the formula (a) or (b).
Patent NZ-526784-A (NZ)
Title: Liquid delivery device and method for operating an ejecting device towards an eye
Inventor: PECLAT CHRISTIAN
IPC: A61H35/02
Filed: 2002-01-29
Abstract: Here is disclosed a device for ejecting a liquid stream towards an eye, the stream moving from a proximal position towards a distal position, the device comprising a housing, a container for the liquid, at least one opening arranged for ejection of the stream and being in fluid communication with the container, a pump mechanism operable to deliver at least part of the liquid from the container through the opening to form the stream and an eyecup with a contact surface arranged for contact with the eye or its facial surroundings, characterized in the improvement comprising that the eyecup is arranged movable with respect to the opening or housing between at least two positions, an active position with the eyecup contact surface at a defined safety distance to the opening and a rest position with the eye-cup contact surface at a position more proximal than in the active position and that a sensor is arranged to allow discrimination between the positions.
Patent NZ-530261-A (NZ)
Title: Pharmaceutical compositions comprising poly-glu,tyr ( polyGT polyEY ) and T cells treated therewith for neuroprotection therapy
Inventor: EISENBACH-SCHWARTZ MICHAL
IPC: A61K35/14
Filed: 2002-06-27
Abstract: Poly-Gly,Tyr can be used for the preparation of a pharmaceutical composition for preventing or inhibiting neuronal degeneration in the central nervous system (CNS) or peripheral nervous system (PNS) for promoting nerve regeneration in the CNS or PNS , for treating an injury in the CNS or PNS, or for a disorder or diseases caused or exacerbated by glutamate toxicity.
Patent NZ-533033-A (NZ)
Title: Process for the manufacture of human mononuclear phagocytic leukocytes
Inventor: FULGA VALENTIN
IPC: A61K35/12
Filed: 2002-11-21
Abstract: A process for the manufacture of human mononuclear phagocytic leukocytes, comprising: (i) isolating monocytes from a blood sample of an individual and suspending the monocytes in a suitable medium (herein "the medium"); (ii) processing skin segments from the same individual, removing the epidermis, sonicating the dermis segments in the medium in the presence of antibiotics, soaking the sonicated dermis segments in the fresh medium in the presence of antibiotics, and rinsing with the fresh medium in the absence of antibiotics; (iii) coincubating the monocytes of step (i) with rinsed dermis segments of step (ii); (iv) removing the dermis segments from the incubation mixture and sedimenting the obtained activated mononuclear phagocytic leukocytes by centrifugation; (v) washing and resuspending the activated mononuclear phagocytic leulcocytes in the medium; and (vi) evaluating the culture for its suitability for human administration.
Patent NZ-535504-A (NZ)
Title: Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins and their use to treat inflammatory disorders
Inventor: KONRADI ANDREI W
IPC: A61P29/00
Filed: 2003-05-27
Abstract: Compounds of formula (I) are described wherein: X is fluoro, chloro or bromo p is an integer from 0 to 3 R1 and R3 together with the nitrogen atom to which they are bound form an azetidinyl, pyrrolidinyl, pyrrolyl, 2,5-dihydopyrrol-1-yl, piperidinyl, or 1,2,3,6-tetrahydo-pyridin-1-yl R2 is selected from the group consisting of lower alkyl, lower alkenyl and lower alkylenecycloalkyl. Pharmaceutical compositions comprising the compounds are useful for the treatment of disease mediated by alpha4 integrins, such as inflammatory diseases and rheumatoid arthritis.
Patent NZ-537392-A (NZ)
Title: The lutein and zeaxanthin components in infant formula may be in the form of free xanthophylls or xanthopyll esters
Inventor: ZIMMER JOHN PAUL
IPC: A23L33/00
Filed: 2003-06-05
Abstract: Described is an infant formula composition in liquid form comprising lutein and zeaxanthin in an amount of 6 to 230 mcg/litre
Patent NZ-539371-A (NZ)
Title: Acid addition salts of certain [2-(9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl)ethyl]carbamic acid alkyl esters as chemical intermediate for the preparation of oxabispidine compounds
Inventor: CLADINGBOEL DAVID
IPC: C07D498/08
Filed: 2003-10-13
Abstract: Disclosed herein is an acid addition salt of a compound of formula (I), wherein R2 represents C1-6 alkyl (optionally substituted and/or terminated by one or more substituents selected from -OH, halo, cyano, nitro and aryl) or aryl, wherein each aryl and aryloxy group, unless otherwise specified, is optionally substituted.
Patent NZ-541431-A (NZ)
Title: Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit
Inventor: GOTWALS PHILIP
IPC: C07K16/28
Filed: 2000-04-21
Abstract: Disclosed is the use of a anti-alpha4 antibody or fragment thereof for the preparation of a pharmaceutical composition for the treatment of pulmonary fibrosis in a subject in need of treatment thereof. The anti-alpha4 antibody is an antagonist of an interaction between an alpha4 subunit-bearing integrin and a ligand for an alpha 4 subunit bearing integrin. With a proviso that the antigen binding region is not derived from a variable domain of the antibody produced by the cell line ATCC CRL 11175 and two other peptide sequences.
Patent NZ-541789-A (NZ)
Title: Collapsible boat hull
Inventor: AGER GAVIN RONALD
Filed: 2005-08-12
Abstract: A collapsible boat hull comprising: a pair of bottom panels, each bottom panel having a first continuous hinge along an inner edge thereof and a second continuous hinge along an outer edge thereof; and a pair of side panels, each side panel being connected to an adjacent bottom panel along a respective second continuous hinge, the first and second continuous hinges each having spines, the spines having resilient flexibility along respective longitudinal and transverse planes thereof, thereby facilitating the bottom and side panels to be moved between a folded configuration and an erected configuration. In the erected configuration, each side panel and its adjacent bottom panel provide a tensile force to each other through their respective second continuous hinge, the tensile force causing portions of the panels to form a concave curvature to define the sides of the boat hull.
Patent NZ-542457-A (NZ)
Title: Manufactured seed having a live end seal coating
Inventor: CARLSON WILLIAM C
IPC: A01H/
Filed: 2005-09-19
Abstract: Disclosed is an artificial seed, comprising: (a) a seed shell, (b) a restraint disposed within the seed shell and having a cavity housing an embryo, (c) a primary end seal attached to one end of the seed shell, (d) a secondary end seal disposed over the primary end seal, and (e) a tertiary seal attached to the secondary end seal. Alternatively disclosed is an artificial seed, comprising: (a) a seed shell having a cavity sized and configured to receive an embryo, (b) a live end seal attached to the seed shell and positioned to substantially seal the embryo within the seed shell, and (c) a tertiary seal attached to the live end seal, the tertiary seal containing an anti-microbial agent for applying a pesticide to a germinating embryo.
Patent NZ-547774-A (NZ)
Title: A blank for a container with inspection openings for indicating level or quality etc of contents
Inventor: D AMATO GIANFRANCO
IPC: B65D25/56
Filed: 2004-12-17
Abstract: A blank (1) for a container is disclosed. The container when assembled has inspection holes created in its wall (3). The blank (1) has an upper (4) and lower peripheral edge (5) and first (6) and second connection edges (7) laterally connecting the peripheral edges. Each of the connection edges (6, 7) extending along overlap regions which when joined together shape the container. At least one peripheral opening (10, 11, 12, 16) is formed in each of the overlap regions, the peripheral openings overlapping one another at least in part upon connection of the overlap regions to form an inspection opening. A film may cover the inspection opening on the inside of the container. The peripheral opening is used to access the contents of the container. A lid may be supplied for the container.
Patent NZ-552753-A (NZ)
Title: 4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof
Inventor: EMONDS-ALT XAVIER
IPC: A61K31/537
Filed: 2005-07-20
Abstract: Disclosed is a compound of formula (I) and a process for preparing the compound in which Ar represents a 3,4-dichlorophenyl or a 3,4-difluorophenyl and R1 represents a phenyl, a 4-chlorophenyl, a 4-fluorophenyl or a 3,4-difluorophenyl and the other substituents are as defined in the specification.
Patent NZ-553969-A (NZ)
Title: Method of preparing delta-9-tetrahydrocannabinol
Inventor: ELSOHLY MAHMOUD A
IPC: G01N30/34
Filed: 2002-11-22
Abstract: Disclosed is a method for the isolation of delta-9-tetrahydrocannabinol (THC) from cannabis plant material in large-scale quantities comprising: a) extracting the Cannabis plant material with a non-polar organic solvent to form an extract; b) removing the solvent from the extract to give an extract residue; c) optionally, subjecting the extract residue to column chromatography to give a residue eluate; d) subjecting one of the extract residue or the residue eluate provided by column chromatography to a first low pressure flash distillation and collecting a first distillate containing THC from a constant boiling range in the distillation; e) optionally, subjecting the first distillate to a second low pressure flash distillation to give a second distillate containing THC; and f) subjecting one of the first distillate obtained from the first flash distillation or the second distillate obtained from the second flash distillation to at least one of column chromatography, normal HPLC, or reversed HPLC to provide a product containing delta-9-tetrahydrocannabinol.
Patent NZ-555496-A (NZ)
Title: Macrocyclic 4-amino-quinazoline derivatives and their use as MTKI
Inventor: FREYNE EDDY JEAN EDGARD
IPC: A61K31/529
Filed: 2005-12-08
Abstract: Disclosed are macrocyclic 4-amino-quinazoline derivatives as represented by the general formula (I), wherein Z is NH, and the other substituents are as defined herein. Also disclosed is a pharmaceutical composition which comprises a pharmaceutically acceptable carrier and, as an active ingredient, an effective kinase inhibitory amount of a compound as described above, for the use in the treatment of conditions such as cancer, diabetes, inflammation and arthritis.
Patent NZ-563202-A (NZ)
Title: Thiophene compounds and thrombopoietin receptor activators
Inventor: MIYAJI KATSUAKI
IPC: C07D333/32
Filed: 2006-07-13
Abstract: A 3-hydroxythiophene-3-yl hydrazide represented by the formula (I): wherein R1 is a phenyl group. R2 is a hydrogen atom or an alkyl group, R3 is a phenyl group, a pyridyl group or a thienyl group and R4 is a hydrogen atom or an alkyl group, a tautomer, prodrug or pharmaceutically acceptable salt of the compound or a solvate thereof. Also disclosed is the use of said hydrazide for increasing platelets.
Patent NZ-568744-A (NZ)
Title: Fluid Sensing apparatus
Inventor: WILSON ALLAN WALTER
IPC: A01J5/01
Filed: 2008-05-29
Abstract: A method of determining the presence of a discrete anomaly within a fluid using a fluid sensing apparatus which includes a resistive transducer and an indicator element is disclosed. The method comprises: a) causing fluid to flow past the resistive transducer; b) receiving at least one signal from the resistive transducer which varies with respect to the presence of a discrete anomaly in contact with the resistive transducer; c) determining a quiescent state of the resistive transducer signal; d) activating the indicator element to indicate the presence of a particular discrete anomaly if the resistive transducer signal varies significantly with respect to the quiescent state.
Patent NZ-570497-A (NZ)
Title: Spiro condensed 4,4'-quinilino-piperidines derivatives as modulators of muscarinic receptors
Inventor: MAKINGS LEWIS R
IPC: C07D471/10
Filed: 2007-02-22
Abstract: Disclosed are spiro[piperidine-4,4'-quinoline] and spiro[piperidine-4,4'-indol] derivatives as represented by the general formula (I), wherein R1 is an optionally substituted aliphatic or NR6R'6; Each of R6 and R'6 is independently hydrogen or an optionally substituted aliphatic, or R6 and R'6 together with the nitrogen atom to which they are attached form an optionally substituted 4-7 membered heterocycloaliphatic; L is -(CH2)n-, wherein n is 0-2; R2 is a cycloaliphatic or a heterocycloaliphatic, each of which is optionally substituted with 1-3 of R3; p is 0 or 1; and wherein the remaining substituents are as defined herein. Further disclosed is the use of a compound as defined above for the manufacture of a medicament for treating or reducing the severity of a disease, wherein said disease is selected from CNS derived pathologies, Attention Deficit Hyperactivity Disorder (ADHD), obesity, Alzheimer's disease, various dementias, psychosis associated with CNS disorders, mania, bipolar disorders, pain conditions, Huntington's Chorea, Friederich's ataxia, Gilles de la Tourette's Syndrome, Downs Syndrome, Pick disease, clinical depression, Parkinson's disease, peripheral disorders, bradhycardia, gastric acid secretion, asthma, GI disturbances, and wound healing.
Patent NZ-571201-A (NZ)
Title: DNA Conformation (loop structures) in normal and abnormal gene expression
Inventor: RAMADASS AROUL SELVAM
IPC: C12Q1/68
Filed: 2007-02-19
Abstract: Provided is a method of diagnosing a cancer by detection of abnormal gene expression in an individual comprising determining in a sample from the individual the presence of an abnormal chromosome conformation, said abnormal chromosome conformation being characterized by (1) the presence of a new juxtaposition which is not present during normal expression, or (ii) the absence of at least one juxtaposition which is present during normal gene expression, where said juxtaposition is of two separate regions of a gene, to thereby diagnose whether the individual has cancer.
Patent NZ-580874-A (NZ)
Title: Apparatus and method for measuring three-dimensional shape of a wood block
Inventor: HIRAOKA NORIYUKI
IPC: B23Q17/20
Filed: 2009-11-02
Abstract: Disclosed is an apparatus for measuring three dimensional shape of a generally cylindrical wood block (100). The apparatus includes: a light emitting device (11, 12); an imaging device (20); a position data storage device; a line image position computing device; a distance computing device; and a profile computing device. The light emitting device emits a light beam against the wood block supported rotatably at a spin axis such that illuminated lines extending the length of the block parallel to the spin axis are formed by the light beam at two different positions on the outer surface of the block. The imaging device has a lens and photographs the block with the lines at different positions while it is rotated. The distance computing device determines, by distances between the spin axis and each line, a plurality of cross sections perpendicular to the spin axis.